PMID- 20470770 OWN - NLM STAT- MEDLINE DCOM- 20101004 LR - 20200325 IS - 1879-0712 (Electronic) IS - 0014-2999 (Linking) VI - 640 IP - 1-3 DP - 2010 Aug 25 TI - Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury. PG - 75-81 LID - 10.1016/j.ejphar.2010.04.055 [doi] AB - The present study was to investigate the neuroprotective efficacy and mechanism of Forsythoside B. Male Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 1 h followed by reperfusion for 23 h. Rats received an intravenous bolus injection of Forsythoside B at 15 min after reperfusion. The results showed that Forsythoside B at doses higher than 8 mg/kg produced a significant neuroprotective potential in cerebral ischemia and reperfusion rats. Forsythoside B (20 mg/kg) demonstrated significant neuroprotective activity even after delayed administration at 1 h, 3 h and 5 h after cerebral ischemia and reperfusion. Forsythoside B 20 mg/kg attenuated histopathological damage as demonstrated by smaller brain infarct size and brain edema, decreased cerebral Evans blue extravasation and myeloperoxidase (MPO) activity, inhibited cerebral phosphor-IkappaB-alpha and nuclear transcription factors kappaB (NF-kappaB) expression. Meanwhile, NF-kappaB expression with immunohistochemical staining was reduced, while circulating polymorphonuclear leukocytes was increased. All of these findings suggested that Forsythoside B exerted potent neuroprotective effects with a favorable therapeutic time-window, reduce of cerebral ischemia and reperfusion injury degree, attenuating blood-brain barrier (BBB) breakdown, and its protective effects may be due to inhibition of inflammatory response. CI - Copyright (c) 2010 Elsevier B.V. All rights reserved. FAU - Jiang, Wang-Lin AU - Jiang WL AD - School of Pharmacy, Yantai University, 32# Qingquan Road, Laishan District, Yantai 264003, PR China. FAU - Tian, Jing-Wei AU - Tian JW FAU - Fu, Feng-hua AU - Fu FH FAU - Zhu, Hai-Bo AU - Zhu HB FAU - Hou, Jian AU - Hou J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100512 PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antigens, Nuclear) RN - 0 (Caffeic Acids) RN - 0 (Glucosides) RN - 0 (Glycosides) RN - 0 (NF-kappa B) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neuroprotective Agents) RN - 0 (Rbfox3 protein, rat) RN - 0 (forsythoside B) RN - 45PG892GO1 (Evans Blue) RN - EC 1.11.1.7 (Peroxidase) SB - IM MH - Animals MH - Anti-Inflammatory Agents/*pharmacology/therapeutic use/toxicity MH - Antigens, Nuclear/metabolism MH - Brain Infarction/complications/drug therapy/metabolism/pathology MH - Brain Ischemia/complications/*drug therapy/metabolism/pathology MH - Caffeic Acids/*pharmacology/therapeutic use/toxicity MH - Disease Models, Animal MH - Evans Blue/metabolism MH - Extravasation of Diagnostic and Therapeutic Materials MH - Glucosides/*pharmacology/therapeutic use/toxicity MH - Glycosides/*pharmacology/therapeutic use/toxicity MH - Leukocytes/drug effects MH - Male MH - NF-kappa B/metabolism MH - Nerve Tissue Proteins/metabolism MH - Neurons/drug effects/immunology/metabolism MH - Neuroprotective Agents/*pharmacology/therapeutic use/toxicity MH - Peroxidase/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Reperfusion Injury/complications/*drug therapy/metabolism/pathology EDAT- 2010/05/18 06:00 MHDA- 2010/10/05 06:00 CRDT- 2010/05/18 06:00 PHST- 2009/12/13 00:00 [received] PHST- 2010/03/31 00:00 [revised] PHST- 2010/04/23 00:00 [accepted] PHST- 2010/05/18 06:00 [entrez] PHST- 2010/05/18 06:00 [pubmed] PHST- 2010/10/05 06:00 [medline] AID - S0014-2999(10)00387-0 [pii] AID - 10.1016/j.ejphar.2010.04.055 [doi] PST - ppublish SO - Eur J Pharmacol. 2010 Aug 25;640(1-3):75-81. doi: 10.1016/j.ejphar.2010.04.055. Epub 2010 May 12.